- Report
- October 2024
- 140 Pages
Global
From €2239EUR$2,500USD£1,909GBP
- Report
- February 2025
- 135 Pages
Global
From €13431EUR$14,995USD£11,449GBP
- Report
- January 2024
- 150 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- April 2024
- 115 Pages
Global
From €4031EUR$4,500USD£3,436GBP
- Report
- August 2022
- 120 Pages
Global
From €4031EUR$4,500USD£3,436GBP
- Report
- March 2024
- 200 Pages
Global
From €3717EUR$4,150USD£3,169GBP
- Report
- April 2023
- 160 Pages
Global
From €4433EUR$4,949USD£3,779GBP
- Report
- June 2023
- 200 Pages
Global
From €6718EUR$7,500USD£5,726GBP
- Report
- April 2023
- 240 Pages
Global
From €3135EUR$3,500USD£2,672GBP
- Report
- June 2022
- 95 Pages
Global
From €3538EUR$3,950USD£3,016GBP
- Report
- April 2022
- 191 Pages
Global
From €3986EUR$4,450USD£3,398GBP
- Report
- June 2024
- 200 Pages
Global
From €7121EUR$7,950USD£6,070GBP
- Report
- May 2024
- 182 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- February 2024
- 110 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- April 2023
- 115 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- October 2022
- 81 Pages
Global
From €3130EUR$3,495USD£2,669GBP
- Report
- November 2020
- 36 Pages
Global
From €3578EUR$3,995USD£3,050GBP
- Report
- April 2023
- 116 Pages
Global
From €4031EUR$4,500USD£3,436GBP
- Report
- August 2024
- 133 Pages
China
From €1612EUR$1,800USD£1,374GBP
- Report
- August 2024
- 101 Pages
China
From €1612EUR$1,800USD£1,374GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more